IPO tracker: After another three pricings bring total raise close to $3B, debuts expected to slow in short week
The Endpoints News team is continuing to track IPO filings for 2021, and we’re off to another hot start after 2020’s record year.
There have already been 16 biotechs to debut on the Nasdaq so far this year, with Sana leading the way. Its massive IPO raise, which was updated to more than $675 million after the underwriters exercised all their options, makes up the lion’s share of a combined $2.86 billion fundraise.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.